EcoDrugPlus

Retinoid X Receptor Gamma

Ensembl ID : ENSRFEG00010016975
Gene Symbol: RXRG
1 Cross references
274 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSRFEG00010001575
Gene Symbol: RPL11
1 Cross references
152 Possible Orthologues:

Ribosomal Protein L12

Ensembl ID : ENSRFEG00010013892
Gene Symbol: RPL12
1 Cross references
227 Possible Orthologues:

Ribosomal Protein L13

Ensembl ID : ENSRFEG00010005364
Gene Symbol: RPL13
1 Cross references
268 Possible Orthologues:

Ribosomal Protein L13a

Ensembl ID : ENSRFEG00010009364
Gene Symbol: RPL13A
1 Cross references
280 Possible Orthologues:

Ribosomal Protein L14

Ensembl ID : ENSRFEG00010016459
Gene Symbol: RPL14
1 Cross references
259 Possible Orthologues:

Ribosomal Protein L18a

Ensembl ID : ENSRFEG00010018283
Gene Symbol: RPL18A
1 Cross references
164 Possible Orthologues:

Ribosomal Protein L22

Ensembl ID : ENSRFEG00010009271
Gene Symbol: RPL22
1 Cross references
90 Possible Orthologues:

Ribosomal Protein L27

Ensembl ID : ENSRFEG00010011209
Gene Symbol: RPL27
1 Cross references
203 Possible Orthologues:

Ribosomal Protein L30

Ensembl ID : ENSRFEG00010016148
Gene Symbol: RPL30
1 Cross references
322 Possible Orthologues:

Ribosomal Protein L32

Ensembl ID : ENSRFEG00010018162
Gene Symbol: RPL32
1 Cross references
59 Possible Orthologues:

Ribosomal Protein L35

Ensembl ID : ENSRFEG00010011212
Gene Symbol: RPL35
1 Cross references
258 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).